Published in

Lippincott, Williams & Wilkins, Pharmacogenetics and Genomics, 6(27), p. 227-231, 2017

DOI: 10.1097/fpc.0000000000000280

Links

Tools

Export citation

Search in Google Scholar

Evaluation of KDR rs34231037 as a predictor of sunitinib efficacy in patients with metastatic renal cell carcinoma:

Journal article published in 2017 by María Apellániz-Ruiz ORCID, Meta H. Diekstra, Juan M. Roldán, Epie Boven, Daniel Castellano, Hans Gelderblom, Ron H. J. Mathijssen, Jesse J. Swen ORCID, Stefan Böhringer, Jesús García-Donás, Brian I. Rini, Henk-Jan Guchelaar ORCID, Cristina Rodríguez-Antona
This paper was not found in any repository, but could be made available legally by the author.
This paper was not found in any repository, but could be made available legally by the author.

Full text: Unavailable

Green circle
Preprint: archiving allowed
Upload
Orange circle
Postprint: archiving restricted
Upload
Red circle
Published version: archiving forbidden
Policy details
Data provided by SHERPA/RoMEO